ERK pathway agonism for cancer therapy: evidence, insights, and a target 
discovery framework

Timofeev, Oleg; Giron, Philippe; Lawo, S.; Pichler, Martin; Noeparast, Maxim

doi:10.1038/s41698-024-00554-5

Local TagsRelease HistoryDetailsSummary

ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework

Timofeev, O., Giron, P., Lawo, S., Pichler, M., & Noeparast, M. (2024). ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework. npj Precision Oncology, 8: 70. doi:10.1038/s41698-024-00554-5.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/21.11116/0000-000F-0377-8 Version Permalink: https://hdl.handle.net/21.11116/0000-000F-0378-7

Genre: Journal Article

Files

show Files

Locators

show

Creators

show

hide

Creators:
Timofeev, Oleg, Author
Giron, Philippe, Author
Lawo, S.¹, Author
Pichler, Martin, Author
Noeparast, Maxim, Author

Affiliations:
1CRISPR Screening, Core Facilities, Max Planck Institute for Biology of Ageing, Max Planck Society, ou_3394014

Content

show

Details

show

hide

Language(s):

Dates: Published Online: 2024-03-14

Publication Status: Published online

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: -

Identifiers: DOI: 10.1038/s41698-024-00554-5

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: npj Precision Oncology

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: -

Pages: - Volume / Issue: 8 Sequence Number: 70 Start / End Page: - Identifier: ISSN: 2397-768X